EMPLOYMENT AGREEMENTEmployment Agreement • February 12th, 2024 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 12th, 2024 Company Industry JurisdictionThis Employment Agreement (this “Agreement”), effective as of February 8, 2024 by and between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and Jeffrey S. Cole (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.
EMPLOYMENT AGREEMENTEmployment Agreement • January 25th, 2023 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 25th, 2023 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of January 24, 2023 by and between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and Matthew K. Szot (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.
EMPLOYMENT AGREEMENTEmployment Agreement • January 25th, 2023 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 25th, 2023 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of September 21, 2022 by and between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and Douglas Losordo (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.
EMPLOYMENT AGREEMENTEmployment Agreement • September 22nd, 2022 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledSeptember 22nd, 2022 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of ___________, 2022 by and between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and Matthew K. Szot (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.
EMPLOYMENT AGREEMENTEmployment Agreement • September 22nd, 2022 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 22nd, 2022 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of September 21, 2022 by and between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) and Douglas Losordo (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.
EMPLOYMENT AGREEMENTEmployment Agreement • February 10th, 2022 • S&W Seed Co • Agricultural production-crops • Colorado
Contract Type FiledFebruary 10th, 2022 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is entered into as of November 13, 2021 (the “Effective Date”) by and between S&W Seed Company, a Nevada corporation (the “Company”) and Betsy Horton (“Executive”). Together, Executive and the Company are sometimes referred to as the “Parties.” Capitalized terms not otherwise defined herein shall have the meanings set forth in Section 9 below.